![]() Soligenix Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases. | Angiochem Angiochem is a biotech company discovering and developing medications that are crossing the blood-brain barrier (BBB) to treat brain diseases. | ||
Founding Date | Founding Date 2020 | Founding Date 1987 | Founding Date 2003 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Austin, US HQ Ames, US | Locations Princeton, US HQ | Locations Westmount, CA HQ |
Employees | Employees 333% increase | Employees 1422% decrease | Employees 10 |
Valuation ($) | Valuation ($) 35.5 m | Valuation ($) 8.7 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($34m) (FY, 2023) | Net income ($11.1m) (FY, 2025) | Net income N/A |

Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.
View companyAngiochem is a biotech company discovering and developing medications that are crossing the blood-brain barrier (BBB) to treat brain diseases.
View company